Proteome analysis of human androgen-independent prostate cancer cell lines: Variable metastatic potentials correlated with vimentin expression

被引:52
|
作者
Wu, Mingfu
Bai, Xiangyang
Xu, Gang
Wei, Juncheng
Zhu, Tao
Zhang, Yongtao
Li, Qiong
Liu, Ping
Song, Anping
Zhao, Liangpin
Gang, Chen
Han, Zhiqiang
Wang, Shixuan
Zhou, Jianfeng
Lu, Yunpin
Ma, Ding
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Res Ctr, Wuhan 430030, Hebei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan 430030, Hebei, Peoples R China
关键词
2-DE; androgen-independent prostate cancer; metastasis; vimentin;
D O I
10.1002/pmic.200600643
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To better understand the molecular mechanisms of prostate cancer (PCA) dissemination and to develop new anti-metastasis therapies, key regulatory molecules involved in PCA metastasis were identified in two human androgen-independent PCA cell lines, highly metastatic 1E8-H and lowly metastatic 2B4-L, cells. Through 2-DE and MS analyses, 12 proteins with different expression levels in the two cell lines were identified. The following proteins were found to be significantly up-regulated in 1E8-H cells compared with 2B4-L cells: gp96 precursor, calreticulin precursor, vimentin (VIM), Hsp90 alpha, peroxiredoxin 2, HNRPH1, ezrin, T-complex protein 1, alpha subunit, and hypothetical protein mln2339. In contrast, heart L-lactate dehydrogenase H chain, annexin I, and protein disulfide isomerase were notably down-regulated in 1E8-H cells compared with 2B4-L cells. To our knowledge, this study is the first to demonstrate that up-regulation of VIM expression positively correlates with the invasion and metastasis of androgen-independent PCA.
引用
收藏
页码:1973 / 1983
页数:11
相关论文
共 50 条
  • [31] Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2004, 91 : 1425 - 1427
  • [32] Androgen-independent prostate cancer treated with resection of the solitary metastatic site
    Pruthi, Raj S.
    Hubbard, J. Slade
    Kouba, Erik
    Wallen, Eric
    UROLOGIA INTERNATIONALIS, 2007, 79 (04) : 371 - 372
  • [33] MUTATION OF THE ANDROGEN-RECEPTOR GENE IN METASTATIC ANDROGEN-INDEPENDENT PROSTATE-CANCER
    TAPLIN, ME
    BUBLEY, GJ
    SHUSTER, TD
    FRANTZ, ME
    SPOONER, AE
    OGATA, GK
    KEER, HN
    BALK, SP
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21): : 1393 - 1398
  • [34] Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
    Christos N. Papandreou
    Badar Usmani
    Yiping Geng
    Thomas Bogenrieder
    Ronald Freeman
    Sherwin Wilk
    Connie L. Finstad
    Victor E. Reuter
    C. Thomas Powell
    David Scheinberg
    Catherine Magill
    Howard I. Scher
    Anthony P. Albino
    David M. Nanus
    Nature Medicine, 1998, 4 : 50 - 57
  • [35] Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
    Papandreou, CN
    Usmani, B
    Geng, YP
    Bogenrieder, T
    Freeman, R
    Wilk, S
    Finstad, CL
    Reuter, VE
    Powell, CT
    Scheinberg, D
    Magill, C
    Scher, HI
    Albino, AP
    Nanus, DM
    NATURE MEDICINE, 1998, 4 (01) : 50 - 57
  • [36] Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model
    Balaji, KC
    Rao, PS
    Smith, DJ
    Louis, S
    Smith, LM
    Sherman, S
    Bacich, D
    O'Keefe, D
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) : 313 - 320
  • [37] Catalytically active peptidylglycine α-amidating monooxygenase in the media of androgen-independent prostate cancer cell lines
    Trendel, Jill A.
    Ellis, Nicole
    Sarver, Jeffrey G.
    Klis, Wieslaw A.
    Dhananjeyan, Mugunthu
    Bykowski, Crystal A.
    Reese, Michael D.
    Erhardt, Paul W.
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (08) : 804 - 809
  • [38] Myc confers androgen-independent prostate cancer cell growth
    Bernard, D
    Pourtier-Manzanedo, A
    Gil, J
    Beach, DH
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (11): : 1724 - 1731
  • [39] Interaction of tamoxifen, genistein, and vitamin E in the growth inhibition of human androgen-independent prostate cancer cell lines.
    Hugo, ER
    Hartman, D
    Rees, P
    Fritz, D
    Hurst, B
    Carter, JH
    CLINICAL CANCER RESEARCH, 1999, 5 : 3737S - 3737S
  • [40] Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer
    Ohlmann, C. -H.
    Markert, E.
    Gerharz, M.
    Pfister, D.
    Dienes, H. -P
    Engelmann, U.
    Heidenreich, A.
    UROLOGE, 2008, 47 (09): : 1218 - 1223